Sanofi (SNY) Net Income towards Common Stockholders (2009 - 2026)
Sanofi's Net Income towards Common Stockholders was $39.52 million in the quarter ended Jun 30, 2026, up 772.8% from $4.53 million a year earlier and up 462.6% from the prior quarter.
Powered by 
Analysis
Sanofi (SNY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sanofi's Net Income towards Common Stockholders was $46.7 million through Jun 30, 2026, down 34.5% year-over-year; for the year ended May 1, 2025, it came in at $40.95 million.
- Net Income towards Common Stockholders shows a five-year compound annual growth rate of -0.1% (years ended May 2020 to May 2025).
- In earlier years, Net Income towards Common Stockholders was $62.78 million in the year ended Dec 31, 2024, $119.1 million in the year ended Dec 31, 2022 (+79.7%) and $66.27 million in the year ended Dec 31, 2021 (+61.2%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Net Income towards Common Stockholders since the quarter ended Dec 31, 2022.
- Compared with a year earlier, Net Income towards Common Stockholders was higher in five of the last six quarters, with growth averaging 150.8%.
- The best year-over-year quarter for Net Income towards Common Stockholders over five years was the quarter ended Jun 30, 2026 (growth of 772.8%); the worst was the quarter ended Sep 30, 2022 (a decline of 90.1%).
- Per Business Quant data, SNY's Net Income towards Common Stockholders in the three quarters before the quarter ended Jun 30, 2026 was $7.02 million (quarter ended Mar 31, 2026), -$36.09 million (quarter ended Dec 31, 2025) and $36.24 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Sanofi | 50.74 Bn | 17.26 Bn | 10.79 Bn | 398.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 398.69 Mn |
| Mar 31, 2026 | 1.89 Bn |
| Dec 31, 2025 | -7.70 Bn |
| Sep 30, 2025 | 10.07 Bn |
| Jun 30, 2025 | 4.46 Bn |
| Mar 31, 2025 | 1.97 Bn |
| Dec 31, 2024 | 533.23 Mn |
| Sep 30, 2024 | 3.09 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | -597.15 Mn |
| Sep 30, 2023 | 2.75 Bn |
| Jun 30, 2023 | 1.56 Bn |
| Mar 31, 2023 | 2.14 Bn |
| Dec 31, 2022 | 10.14 Bn |
| Sep 30, 2022 | 2.09 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 2.25 Bn |
| Dec 31, 2021 | 1.29 Bn |
| Sep 30, 2021 | 2.72 Bn |
API Access
Sanofi Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();